News - Mainstay Medical

Category: News

A ‘Squishing Sound’ in His Back Led to Decades of Back Pain. A New Device Changed His Life

A Bone to Fix Podcast

ReActiv8 Restorative Neurostimulation: A Novel, Long-term Treatment Option for Mechanical Chronic Low Back Pain

Aches and Gains Podcast

Life Before & After ReActiv8

The Spine Surgeons Dilemma for Patients with Mechanical CLBP

3 Year Data Results Revealed for ReActiv8 Restorative Neurostimulation

Mainstay Medical Announces the Publication of “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact”

Mainstay Medical Announces Publication of Post-Market Clinical Trial Data from Ongoing ReActiv8®-C Study in Chronic Low Back Pain Patients

November 22, 2022

ReActiv8 Trial 3 Year Data

ReActiv8-B Trial 3-Year Patient Outcomes Data Publication in Neuromodulation

October 11, 2022

ReActiv8 Neurostimulation Therapy Recommended to be Used in UK’s National Health Service

October 11, 2022

Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™

September 28, 2022

ReActiv8-B Clinical Trial 2-Year Data Publication

January 6, 2022

Mainstay Medical Announces Appointment of Jeffrey Dunn and Eric Major to its Board of Directors

December 14, 2021

Mainstay Announces Limited Commercial Launch of ReActiv8® in the U.S.